13.08.2024
Omówienie artykułu: Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial.
K.E. Kjorholt i wsp.
Lancet Rheumatology, 2024; 6: e268–e278